- Specialty dentists’ compensation has climbed 39% since 2019
- 4 systems, 3 days, 5 new proposed hospitals: Inside North Carolina’s build race
- OpenAI’s growing healthcare footprint
- The hospital AI names 1st in all 50 states
- ASCs’ block time hoarding problem
- Oregon prosecutors urge state to fix mental health system
- Ascension Florida system taps CEO
- Arkansas lab pays $30M to settle kickback allegations tied to gastroenterology practices
- Radiology group sues Virginia hospital
- FDA approves 1st oral antibiotic for complicated UTIs
- The case for layering behavioral healthcare models
- UNC Health files CONs for hospitals in Wilmington, Asheville: 5 things to know
- Why dentistry needs a revamp
- Nova Southeastern launches 1st anesthesiologist assistant program in Nevada
- 12 behavioral health services, facility closures | 2026
- Higher, short-acting opioid doses linked to 8% lower discharge risk: 4 notes
- Cardiologists push back on CMS’ proposed pay policy changes
- The GI malpractice landscape in 5 numbers
- Saint Peter’s relocates vascular surgery practice with father-son surgeon team
- PBMs take Tennessee, Illinois to federal court over pharmacy laws
- Bankrupt hospital loses court bid to force higher BCBS Alabama rates
- Oklahoma hospital opens 17K-square-foot surgery center
- States ranked by Medicaid prescription drug spend
- What’s going on with price transparency laws?
- 14,700 bottles of antidepressant recalled over impurity concerns
- Physician practice M&A is booming, but buyers are getting more selective
- 7 DSOs making headlines
- 4 dental industry deals totaling $937M
- Ebola Infections Climb, Could Take Year To Contain, Health Officials Say
- Borland Groover opens new location
- How Northwell is using paramedics to close behavioral healthcare gaps
- Feeling Sleepy During the Day? It Could Be a Warning Sign for High Blood Pressure
- FTC, states sue transgender health association over 'misleading' gender care guidance
- Healthcare organizations still struggle to operationalize AI at scale: Arcadia survey
- Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
- Women Might Lower Their Heart Risk By Lifting Weights, Study Says
- Major League Pitchers Might Avoid Elbow Injuries By Altering Their Approach, Simulation Suggests
- Personalized Brain Implant Provides Step-By-Step Walking Boost For Parkinson's Patients
- Birth Control Pills Might Increase Binge Eating Risk, Study Finds
- Amid industry’s cell therapy automation push, Cellares and Ori dominate the field: report
- Most Americans Are Surviving Cancer. But The Mental Health Challenges Can Persist.
- Listen to the Latest ‘KFF Health News Minute’
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Arrests of Immigrant Parents Create Mental Health Crisis for Children
- Readers Curse Medical Debt and Defend Spelling Therapy
- Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix
- 20 new behavioral health study findings to know
- 31 behavioral health executive moves to know
- Centerstone names COO
- 5 new leaders joining DSOs
- Ohio children’s hospital launches pediatric dentistry program
- The hidden marketing value of teledentistry tools
- One Medical Seniors reports data breach of third-party vendor impacting 'limited' number of patients
- 10 things to know about the ADA’s successful pilot Medicaid program
- Cal Dental USA adds strategic growth consultant
- 8 DSO moves reshaping dentistry
- HHS unveils $708M in behavioral health funding
- U.K. Moves To Ban Social Media For Children
- Pregnant Woman Exposed to 45 Common Chemicals, Study Finds
- OhioHealth reaches settlement with DOJ, Ohio AG on antitrust lawsuit
- 4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line
- Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer
- OIG report raises red flags about maternal health 'ghost networks' in Medicaid managed care
- Lantern, Marathon Health team up to launch integrated care management model
- Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility
- Whoop, HealthEx partner to connect members’ medical records and biometric data
- GSK runs first DTC ad for would-be asthma blockbuster Exdensur
- Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports
- After FDA sign-off, Colorado's drug import plan faces tough road ahead
- Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs
- Surgical Menopause Tied To Worse Sexual And Urinary Symptoms
- Post-Op Delirium Common In Seniors, But Not All Hospitals Screen For It
- Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup
- Why one life insurer is going big on health incentives
- Early-Onset Cancers Are On The Rise. Knowing Your Family History Is Crucial.
- Minimally Invasive Procedure Eases Arthritis Knee Pain, Study Finds
- Tennessee Pharmacies Sell Potent Ivermectin, Led by Anti-Vaccine Doctor Who’s Taken ‘Bucketloads’
- More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
- Democrats Seek To Spotlight Rising Health Costs by Forcing Vote on Trump Regulation
- Health services deal value holds steady in 2026 with higher bar for investment: PwC
- CMS tightens oversight of accreditation organizations, limits fee-based consulting
- MedPAC offers a look at enrollment hiccups for Medicare beneficiaries
- CDC, FDA Tackle New World Screwworm, Including Drug Authorization
- 'Biopharma ecosystem is back to full health,' fueled by M&A: PwC
- Lifestyle Changes Can Reduce Your Risk For Multiple Chronic Diseases
- US telehealth utilization climbs 10.1% in Q1, led by mental health visits: Fair Health
- FDA, UK drug regulator deepen transatlantic ties with new liaison program
- People Walk, Exercise Less After Starting Ozempic, Zepbound
- Family Finances Shape Children’s Brain Development, Study Finds
- At-Home Blood Pressure Monitoring Reduces Risk of Heart Attack, Stroke
- Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom
- Uncovr secures $7M in seed funding for AI surgical documentation platform
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Many Men Are Prescribed Testosterone Without Proper Testing
- Backed by Threat of Clawbacks, Feds Wield Tight Grip on $50B Rural Health Fund
- Early-Onset Cancers Are on the Rise. Knowing Your Family History Is Crucial.
- Stealth BioTherapeutics removes cloak to become Mighty
- Recipharm channels ‘multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand
- DeepIntent gives Helix an AI twist to help marketers query data
- PhRMA talks up the power of ‘Medicines First’ in new campaign
- Centene offering staff buyouts as it navigates murky ACA waters
- KFF: Insurer participation in the ACA marketplaces declined from 2025 to 2026
- Organic Baby Formula Recalled Following Botulism Cases
- Germany backs off plan to install variable discount pricing on drugs: report
- Judge tosses multiple provisions of CMS' 2025 ACA program integrity rule
- FDA Approves First Over-the-Counter Glucose Monitor for Children, The Stelo Glucose Biosensor System
- 47% of US adults say corporate health insurers ‘primary drivers’ of rising health costs
- You've Won The Game
- IQVIA taps AI to put overlooked prescribers on marketers’ maps
- CMS creates new health tech office to lead interoperability efforts, digital products
- Many Patients Stop And Restart GLP-1 Meds, Study Finds
- Merck's Welireg-Keytruda pairing sticks the landing in adjuvant kidney cancer treatment with new FDA nod
- Sanofi, once on FDA course for speedy approval, gains late expansion for Tzield
- Half Of U.S. Parents Track Their Adult Children’s Location
- Taking GLP-1s While On BP Meds May Up Your Risk Of Dizzy Spells, Fainting
- Trust In CDC Plummets Under Trump Administration, New Poll Shows
- Fentanyl Users Take Daily Doses 60 Times The Lethal Level
- Eisai snares government manufacturing grant as it brings Leqembi packaging to UK with $65M expansion
- Final Rules For Medicaid Work Requirements Are Out. Here's What You Need To Know.
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Yale New Haven Health System deploys Rad AI solutions across its network as Microsoft sunsets PowerScribe 360
- Influencers, Booze And Teens: What's Showing Up In Their Feeds?
- Health 'War Room,' Digital Tools Are Tracking Disease Risks During World Cup
- Cedar’s voice AI agent has handled nearly 400K patient calls since April 2025 launch
- Food Labels and Restrictions Can Lower Childhood Obesity Rates, Study Finds
- Tourette Patients Face High Suicide Risk, Pain And Discrimination
- Have A Risk-Taking Teen? This Brain Chemical Might Be Responsible, Researchers Say
- Sepsis, Lung Infection Patients See No Benefit From Remote Monitoring
- Overlooked Social Connections Can Prevent Suicide
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Vitamin C May Be Key To A Healthier Brain As You Age
- New Vaccine Schedule Released By American College of Obstetricians & Gynecologists
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Can Fasting Treat Gum Disease? Study Finds Reduced Inflammation
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- How lab data powers precision commercialization to drive therapy adoption
- Why one health system invested in its PBM as GLP-1 costs surged
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks at the Investor Advisory Committee Meeting
- Base Case: Remarks at the IC3 Blockchain Camp
- Eli Lilly cuts 340B discounts for hospitals resisting its claims data submission policy
Michigan healthcare freedom community forum
Dr. Joseph Varon, M.D. is a prominent critical care physician Houston, Texas. He has made significant contributions to the field of medicine, particularly during the COVID-19 pandemic. His current positions are:
- Chief of Staff at United Memorial Medical Center
- Chairman of the Board at United General Hospital
- President of the Independent Medical Alliance
- Professor of Acute and Continuing Care at the University of Texas Health Science Center in Houston
- Clinical Professor of Medicine at the University of Texas Medical Branch in Galveston
Dr. Varon takes exception to the muzzling of physicians which began during the COVID pandemic as public health officers ruthlessly stifled all medical challenges to politically approved treatments:
https://brownstone.org/articles/what-covid-policy-did-to-doctors-who-refused-to-stay-silent/
What Covid Policy Did to Doctors Who Refused to Stay Silent
By Joseph Varon - March 14, 2026The sound I remember most from the early days of Covid-19 is not the alarms. It was the silence between them. Intensive care units became Covid wards. Monitors glowed in dark rooms while ventilators pushed air into failing lungs. Nurses, shrouded in protective gear, moved quietly. Families were absent—barred from being with loved ones in their final hours.
One night at 3 am, I stood by a patient whose oxygen levels were steadily falling. Outside the room, another patient crashed. Down the hall, a third awaited intubation. For months, this was every night. For 715 consecutive days, I worked in that environment without taking a single day off. In moments like that, medicine becomes very simple. There are no politics in an ICU at 3 am. There is only a physician and a patient, and the responsibility to do everything possible to keep that patient alive.
That philosophy has guided physicians for generations. It is the foundation of clinical medicine: when a patient is dying, you explore every reasonable option that might help.
Yet during Covid, something extraordinary happened. What made the shift so jarring was not simply the presence of disagreement. Physicians have always disagreed. In fact, disagreement is the normal language of medicine. Grand rounds exist for that reason. Journal clubs exist for that reason. The entire structure of scientific publication—from peer review to replication—exists because medicine advances through argument, not obedience. During the pandemic, however, the culture of medicine changed almost overnight. Instead of asking whether a treatment might work, institutions began asking whether discussing that treatment might create the wrong public message. The priority quietly shifted from discovery to control.
Scientific debate faded. Physicians who questioned policies or explored treatments were treated as threats rather than colleagues. Instead of debate, there was enforcement.
Hospitals warned physicians to stay quiet. Medical boards hinted at disciplinary action. Social media platforms censored discussion of therapies that doctors around the world were actively studying. Media outlets portrayed dissenting physicians as reckless or dangerous. What had once been normal scientific discourse was suddenly labeled misinformation.
To physicians trained in earlier decades, this shift was deeply unsettling. Medicine has always lived with uncertainty. Treatments begin as hypotheses and evolve through observation and debate. During the AIDS crisis, clinicians tried multiple strategies before effective therapies emerged. The same was true for sepsis, trauma care, and organ transplantation. No one expected immediate unanimity. Yet during Covid, uncertainty itself became suspect. If a physician acknowledged that evidence was incomplete—or that clinical experience suggested alternative approaches—those statements were sometimes interpreted as challenges to authority rather than contributions to knowledge.
For those of us working inside the ICU, the shift was startling. Medicine had always thrived on disagreement. Physicians argued over treatment strategies, debated emerging evidence, and learned from one another’s experiences. The process was messy, sometimes loud, and occasionally uncomfortable—but it was also the engine of medical progress. During Covid, that process was replaced by something else entirely: the expectation of unanimity. I experienced this transformation firsthand.
During the pandemic, I spoke publicly about what I was seeing inside the ICU—what treatments appeared to help, what policies seemed ineffective, and why physicians needed the freedom to treat patients according to their clinical judgment.
Those comments triggered a reaction that made clear how medical freedom—a core value of our profession—had come under threat. Professional attacks followed, and colleagues were pressured to distance themselves. Invitations disappeared. Media narratives were constructed that bore little resemblance to the reality many of us were witnessing inside hospitals. But perhaps the most revealing response was silence.
Privately, many physicians admitted that the environment had become toxic for honest scientific discussion. In quiet conversations they would agree that open debate had been replaced by institutional pressure. Publicly, however, very few were willing to risk speaking. I chose not to remain silent.
That silence did not necessarily mean physicians agreed with what was happening. More often it meant they understood the risks of speaking. Hospitals depend on reputations. Universities depend on funding. Physicians depend on licenses. When the boundaries of acceptable opinion begin to narrow, most professionals instinctively step back. It is not cowardice; it is survival. But the cumulative effect of that silence is profound. When enough physicians remain quiet, the illusion of consensus begins to replace the reality of debate.
Over the course of the pandemic, I gave more than 4,000 television and media interviews, attempting to explain what physicians were seeing on the front lines and defending the principle that doctors must be allowed to think, question, and treat patients according to their best clinical judgment. The experience was both exhausting and illuminating. Again and again, I found myself explaining basic principles of medicine to audiences who had been told that questioning official policy was somehow dangerous.
Medicine has never advanced through silence. Every major breakthrough in medical history, from antibiotics to organ transplantation, began with physicians willing to challenge prevailing assumptions. Scientific progress depends on disagreement. It requires physicians to ask uncomfortable questions and explore possibilities that established authorities may initially reject. When debate is replaced by enforced consensus, science ceases to function.
That decision to speak carried consequences. Professionally and financially, the cost was substantial. The controversy surrounding Covid treatment debates resulted in lost opportunities, canceled collaborations, and significant professional retaliation. The economic impact was severe, resulting in roughly a 60 percent reduction in my income, a consequence that continues to this day.
Financial pressure has always been one of the most effective tools for enforcing conformity in any profession. Medicine is no exception. Physicians spend decades training, accumulate significant professional responsibilities, and depend on institutional relationships to practice. When controversy threatens those relationships, the safest option is often to say nothing. Many doctors understood this reality during Covid. Some quietly expressed agreement in private conversations but made clear they could not say so publicly. In that environment, silence became the profession’s default posture. For many physicians, that kind of pressure is enough to ensure silence. But the financial cost was never the hardest part.
What made the experience even more disturbing was watching what happened to colleagues who chose to speak openly. Some physicians lost hospital privileges almost overnight. Others faced medical board investigations triggered not by patient complaints, but by their public statements or willingness to question prevailing policies. Careers built over decades were suddenly placed under threat. A number of doctors saw research collaborations vanish, academic appointments quietly withdrawn, and professional reputations publicly attacked. The message became unmistakable: disagreement would carry consequences.
The personal toll was often even greater. Financial pressure, professional isolation, and relentless public scrutiny spilled into physicians’ private lives. I watched colleagues struggle as marriages fractured under the strain of media attacks, legal battles, and the sudden collapse of careers they had spent their lives building. Some left clinical practice entirely. Others retreated from public discussion simply to protect their families. The pandemic revealed something few physicians had previously experienced—the realization that speaking honestly about patient care could place not only one’s career at risk, but one’s personal life as well.
The hardest part was watching medicine surrender one of its most essential principles: the freedom to think and speak for patients. The pandemic response exposed how vulnerable modern medicine has become to political pressure, institutional fear, and media narratives. Decisions that should have remained within the realm of clinical judgment were increasingly dictated by bureaucratic authority.
In theory, medicine is guided by science. In practice, during Covid, it often appeared to be guided by messaging. That realization has prompted an important effort to document what happened during the pandemic and to ensure that physicians’ experiences are not erased from the historical record. One such effort is the COVID Justice initiative, which seeks to collect and document the stories of doctors, nurses, scientists, and patients affected by pandemic policies. The COVID Justice Resolution is an attempt to ensure that the suppression of scientific debate, the censorship of physicians, and the professional retaliation many experienced are openly acknowledged rather than quietly forgotten. The goal is not vengeance. It is accountability and transparency.
If the medical profession refuses to confront what happened during the pandemic—if it pretends that physicians were not pressured, censored, or punished—then the same mistakes will almost certainly be repeated during the next public health crisis.
History shows that institutions rarely correct themselves without accountability. On the front lines, many of us witnessed something deeply troubling: modern medicine’s increasing dependence on bureaucratic authority. When that authority collides with bedside care, physicians can find themselves forced to choose between professional safety and patient advocacy. Every doctor eventually faces that choice. During Covid, many of us faced it together. Some chose silence. Others chose to speak.
Speaking came with consequences. It costs reputations, careers, and, in many cases, substantial income. But the alternative—remaining silent while scientific debate was suppressed and physicians were discouraged from thinking independently—would have been a far greater betrayal of the profession.
Medicine cannot survive if doctors fear speaking freely and challenging consensus on behalf of their patients.
The next public health crisis will come. That is inevitable. When it does, the profession must remember what happened during Covid: how easily fear can replace reason, how quickly debate can be labeled dangerous, and how fragile scientific freedom becomes when institutions decide that certain questions are no longer allowed.
The real lesson of the pandemic is not about a virus. It is about the courage required to defend the integrity of medicine itself. Physicians must remain free to question, to debate, and to innovate in the service of their patients. Without that freedom, medicine becomes little more than bureaucratic compliance dressed in a white coat. And patients deserve far better than that. Because when physicians lose the freedom to question, patients lose something far more precious: the possibility that someone, somewhere, will be willing to challenge the rules in order to save their life.
That is the real price of speaking. The only question now is whether the medical profession still has the courage to pay it.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















